Meeting
2024 ASCO Breakthrough
Outcome analysis of autologous stem cell transplantation in refractory and relapsed Hodgkin lymphoma: Insights from a North African single-institution study.
Authors
Marouane Maaroufi
Department of Clinical Hematology and Pediatric Oncology, 20th August 1953 Hospital, Ibn Rochd University Hospital Center, Casablanca, Morocco
Marouane Maaroufi , Soukaina Douma , Mohamed Rachid , Ilias Aajafir
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics
Sub Track
Real-World Evidence/Real-World Data
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 172)
DOI
10.1200/JCO.2024.42.23_suppl.172
Abstract #
172
Poster Bd #
G3
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma.
First Author: Niloufer Khan
Poster
2013 ASCO Annual Meeting
Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma.
First Author: Amrita Y. Krishnan
Poster
2011 ASCO Annual Meeting
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation (ASCT) for Hodgkin lymphoma (HL).
First Author: B. M. William
Poster
2020 ASCO Virtual Scientific Program
Role of high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma: A systematic review.
First Author: Shaha Nabeel